There was an important win for consumers last week, with the go ahead for the new 60-day prescribing rules for some common medicines. In the past, a cup of tea, a Bex, and a lie-down were go-to remedies when medications were a quick fix for short-term problems. But today's world is different – many people are on one or more daily medications for their long-term health. Traditional 30-day scripts are useful for infections, one-off episodes or when closer monitoring is required. Consumers Health Forum of Australia (CHF) has long pushed for better access to medicines, and 60-day scripts has been a key element to bringing costs down. Widely embraced, Australians want change, and this will bring about fewer low-value health visits, less chance of missing doses, and lower out of pocket costs, freeing up GP visits for more essential health matters. Yearly doctor visits and trips to the pharmacy every two months are set to give relief, with a carefully chosen list of medicines taking effect on September 1, 2023, moving towards a modern consumer-focused medicine policy, and bringing Australia into line with other countries. We acknowledge the advocacy of the many consumers who have been a part of this journey, and our colleagues in other health peaks who share this vision with us. CHF's CEO, Elizabeth Deveny, alongside AMA President Professor Stephen Robson and RACGP President, Professor Nicole Higgins, held a joint press conference on August 10, highlighting how this reduces costs for chronic conditions. CHF launched the '60dayscripts' website and fact sheets in June to address consumer concerns. We'll be updating the website and provide educational resources for consumers so they can have informed conversations with their doctors and pharmacists about how and when they can access the 60-day scripts. As this policy unfolds, CHF remains committed to boosting consumer voices in healthcare policies. But for now, it's time for a cup of tea to celebrate. |